4//SEC Filing
Bregman Marc 4
Accession 0001863113-21-000002
CIK 0001053369other
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 5:00 PM ET
Size
5.5 KB
Accession
0001863113-21-000002
Insider Transaction Report
Form 4
Bregman Marc
CFO, Secretary, Treasurer
Transactions
- Award
Options
2021-05-17$0.06/sh+300,000$16,860→ 300,000 totalExercise: $0.06From: 2022-05-17Exp: 2031-05-17→ Common Stock (300,000 underlying)
Footnotes (2)
- [F1]Options were awarded by the Board of Directors as part of Mr. Bregman's employment agreement.
- [F2]The options will vest over a three-year period, commencing one year from the date of issuance. The first third will vest on May 17, 2022
Documents
Issuer
ELITE PHARMACEUTICALS INC /NV/
CIK 0001053369
Entity typeother
Related Parties
1- filerCIK 0001863113
Filing Metadata
- Form type
- 4
- Filed
- Jul 6, 8:00 PM ET
- Accepted
- Jul 7, 5:00 PM ET
- Size
- 5.5 KB